Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study.

Bone 20120901

Risedronate-associated scleritis: a case report and review of the literature.

Clinical rheumatology 20120901

Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120801

The association between automatic generic substitution and treatment persistence with oral bisphosphonates.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120801

The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120801

Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial.

Journal of Crohn's & colitis 20120801

Lipid profiles within the SABRE trial of anastrozole with and without risedronate.

Breast cancer research and treatment 20120801

Effect of risedronate on bone in renal transplant recipients.

Journal of the American Society of Nephrology : JASN 20120801

Preventive effect of risedronate on bone loss and frailty fractures in elderly women treated with anastrozole for early breast cancer.

Journal of bone and mineral metabolism 20120701

Risedronate improves bone mineral density in Crohn's disease: a complementary mechanism.

Journal of Crohn's & colitis 20120701

Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures?

The Journal of bone and joint surgery. British volume 20120701

Successful treatment of calcific uraemic arteriolopathy with bisphosphonates.

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120514

Long-term outcomes of children and adolescents who had cerebral palsy with secondary osteoporosis.

Current medical research and opinion 20120501

Effects of alendronate and risedronate on bone material properties in actively forming trabecular bone surfaces.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120501

Prospective evaluation of free radicals and antioxidant activity following 6-month risedronate treatment in patients with postmenopausal osteoporosis.

Rheumatology international 20120401

[Simultaneous determination of alendronate, pamidronate, ibandronate and risedronate using ion chromatography with integrated pulsed amperometric detection].

Se pu = Chinese journal of chromatography 20120401

Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity.

Proceedings of the National Academy of Sciences of the United States of America 20120313

Osteoporosis, osteopenia and fracture risk: widening the therapeutic horizons.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20120308

Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301

Adherence to osteoporosis medications amongst Singaporean patients.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301

Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120301

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Current medical research and opinion 20120301

Paget disease of bone - an update.

Australian family physician 20120301

Immediate loading in mandible full-arch: pilot study in patients with osteoporosis in bisphosphonate therapy.

The Journal of oral implantology 20120201

Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120201

Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120201

Three-year experience with risedronate therapy for patients with an increased fracture risk: assessment of proximal femoral bone density and geometry by DXA.

Clinical drug investigation 20120201

Development and validation of a sensitive solid-phase-extraction (SPE) method using high-performance liquid chromatography/tandem mass spectrometry (LC-MS/MS) for determination of risedronate concentrations in human plasma.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120115

Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101

Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101

Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101

Topically administered Risedronate shows powerful anti-osteoporosis effect in ovariectomized mouse model.

Bone 20120101

Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate.

Bone 20120101

Evidence to inform decision makers in Thailand: a cost-effectiveness analysis of screening and treatment strategies for postmenopausal osteoporosis.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20120101

Heel ultrasound can assess maintenance of bone mass in women with breast cancer.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20120101

Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs.

PloS one 20120101

Elcatonin in combination with risedronate is more effective than risedronate alone for relieving back pain in postmenopausal women with osteoporosis.

Biological & pharmaceutical bulletin 20120101

Atypical bilateral pedicle fracture in long-term bisphosphonate therapy.

Spine 20111215

Bisphosphonate treatment delays stress fracture remodeling in the rat ulna.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20111201

The effect of risedronate treatment on serum osteoprotegerin and bone marker levels in postmenopausal women with osteoporosis.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20111201

Once-weekly risedronate for prevention of hip fracture in women with Parkinson's disease: a randomised controlled trial.

Journal of neurology, neurosurgery, and psychiatry 20111201

Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 20111201

Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate.

Bone 20111201

Distinguishing the proapoptotic and antiresorptive functions of risedronate in murine osteoclasts: role of the Akt pathway and the ERK/Bim axis.

Arthritis and rheumatism 20111201

Identifying common trajectories of joint space narrowing over two years in knee osteoarthritis.

Arthritis care & research 20111201

Gastric ulcerogenic and healing impairment effects of risedronate, a nitrogen-containing bisphosphonate in rats. Comparison with alendronate and minodronate.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20111201

Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases.

Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20111201

Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20111101

Effect of stopping risedronate after long-term treatment on bone turnover.

The Journal of clinical endocrinology and metabolism 20111101

Efficacy of different therapeutic regimens on hepatic osteodystrophy in chronic viral liver disease.

European journal of gastroenterology & hepatology 20111101

Ion pairs of risedronate for transdermal delivery and enhanced permeation rate on hairless mouse skin.

International journal of pharmaceutics 20111031

The effect of weekly risedronate on periprosthetic bone resorption following total hip arthroplasty: a randomized, double-blind, placebo-controlled trial.

The Journal of bone and joint surgery. American volume 20111019

Prolonged bisphosphonate release after treatment in women with osteoporosis. Relationship with bone turnover.

Bone 20111001

Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women.

Journal of clinical pharmacy and therapeutics 20111001

Analysis of the comparative effectiveness of 3 oral bisphosphonates in a large managed care organization: adherence, fracture rates, and all-cause cost.

Journal of managed care pharmacy : JMCP 20111001

Longitudinal change in hip fracture incidence after starting risedronate or raloxifene: an observational study.

Journal of bone and mineral metabolism 20110901

Risedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: results of a 2-year follow-up study.

Prostate cancer and prostatic diseases 20110901

Comparison of the effects of elcatonin and risedronate on back and knee pain by electroalgometry using fall of skin impedance and quality of life assessment using SF-36.

Journal of bone and mineral metabolism 20110901

Gastrointestinal tolerability and patterns of switching in patients treated for primary osteoporosis: the Swedish Adherence Register Analysis (SARA).

Calcified tissue international 20110901

In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada.

Current medical research and opinion 20110901

What is the optimal duration of bisphosphonate therapy?

Cleveland Clinic journal of medicine 20110901

Effect of risedronate on osteoblast differentiation, expression of receptor activator of NF-κB ligand and apoptosis in mesenchymal stem cells.

Basic & clinical pharmacology & toxicology 20110801

Greater magnitude of turnover suppression occurs earlier after treatment initiation with risedronate than alendronate.

Bone 20110701

Hip structure analysis of bisphosphonate-treated Japanese postmenopausal women with osteoporosis.

Journal of bone and mineral metabolism 20110701

Bone turnover markers and bone mineral density response with risedronate therapy: relationship with fracture risk and patient adherence.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110701

Effect of early risedronate treatment on bone mineral density and bone turnover markers after liver transplantation: a prospective single-center study.

Transplant international : official journal of the European Society for Organ Transplantation 20110701

Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice.

Bone 20110701

Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study.

The Journal of clinical endocrinology and metabolism 20110701

Simultaneous bilateral subtrochanteric fractures following risedronate therapy.

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20110701

Shotgun proteomics analysis reveals new unsuspected molecular effectors of nitrogen-containing bisphosphonates in osteocytes.

Journal of proteomics 20110610

Effects of risedronate in Runx2 overexpressing mice, an animal model for evaluation of treatment effects on bone quality and fractures.

Calcified tissue international 20110601

Efficacy of risedronate with cholecalciferol on 25-hydroxyvitamin D level and bone turnover in Korean patients with osteoporosis.

Clinical endocrinology 20110601

Evaluation of weekly risedronate treatment in postmenopausal women with osteoprotegerin.

Panminerva medica 20110601

Crystallization products of risedronate with carbohydrates and their substituted derivatives.

Molecules (Basel, Switzerland) 20110504

Effects of risedronate on bone marrow adipocytes in postmenopausal women.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110501

In vitro and in vivo antiplasmodial activities of risedronate and its interference with protein prenylation in Plasmodium falciparum.

Antimicrobial agents and chemotherapy 20110501

Dose-dependent differential effects of risedronate on gene expression in osteoblasts.

Biochemical pharmacology 20110415

Osteoporosis medication and reduced mortality risk in elderly women and men.

The Journal of clinical endocrinology and metabolism 20110401

In brief: delayed-release risedronate (Atelvia).

The Medical letter on drugs and therapeutics 20110321

Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110301

Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110301

Characterization of a new solvate of risedronate.

Journal of pharmaceutical sciences 20110301

Effects of risedronate on cortical and trabecular bone of the mandible in glucocorticoid-treated growing rats.

American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics 20110301

Osteonecrosis of the jaw and the role of macrophages.

Journal of the National Cancer Institute 20110202

[Incidence of hip fractures due to osteoporosis in relation to the prescription of drugs for their prevention and treatment in Galicia, Spain].

Atencion primaria 20110201

A reliable predictive factorial model for entrapment optimization of a sodium bisphosphonate into biodegradable microspheres.

Journal of pharmaceutical sciences 20110201

Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase.

Bone 20110201

Treatments for osteoporosis in people with a disability.

PM & R : the journal of injury, function, and rehabilitation 20110201

Risedronate improves proximal femur bone density and geometry in patients with osteoporosis or osteopenia and clinical risk factors of fractures: a practice-based observational study.

Journal of bone and mineral metabolism 20110101

The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer.

Breast cancer research and treatment 20110101

When do bisphosphonates make the most sense?

The Journal of family practice 20110101

A case of Marinesco-Sjögren syndrome: MRI observations of skeletal muscles, bone metabolism, and treatment with testosterone and risedronate.

Internal medicine (Tokyo, Japan) 20110101

[Bilateral pathological sub-trochanteric fracture in a long-term biphosphonate user].

Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca 20110101

Multiple vertebral compression fractures associated with post partum osteoporosis.

Journal of back and musculoskeletal rehabilitation 20110101

The assessment of regional skeletal metabolism: studies of osteoporosis treatments using quantitative radionuclide imaging.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20110101

The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial.

The Kurume medical journal 20110101

Stress fractures: diagnosis, treatment, and prevention.

American family physician 20110101

Going on a drug holiday?

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20110101

Beneficial effect of risedronate on arterial thickening and stiffening with a reciprocal relationship to its effect on bone mass in female osteoporosis patients: a longitudinal study.

Life sciences 20101218

Risedronate metal complexes potentially active against Chagas disease.

Journal of inorganic biochemistry 20101201

Response of postpoliomyelitis patients to bisphosphonate treatment.

PM & R : the journal of injury, function, and rehabilitation 20101201

Outcome of patients with early breast cancer receiving nitrogen-containing bisphosphonates: a comparative analysis from the Metropolitan Detroit Cancer Surveillance System.

Clinical breast cancer 20101201

Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer.

BJU international 20101101

Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20101101

Effect of risedronate on osteocyte viability and bone turnover in paired iliac bone biopsies from early postmenopausal women.

Calcified tissue international 20101101

How to prevent glucocorticoid-induced osteoporosis.

Cleveland Clinic journal of medicine 20101101

The effects of risedronate and exercise on osteoporotic lumbar rat vertebrae and their sensory innervation.

Spine 20101015

Particulate adducts based on sodium risedronate and titanium dioxide for the bioavailability enhancement of oral administered bisphosphonates.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20101009

Novel bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase.

Bioorganic & medicinal chemistry letters 20101001

Risk of upper gastrointestinal tract events in risedronate users switched to alendronate.

Calcified tissue international 20101001

Diagnosis of Paget's disease of the pelvis using F-18 FDG PET/CT.

International journal of rheumatic diseases 20101001

High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment.

Journal of bone and mineral metabolism 20100901

In vivo microfocal computed tomography and micro-magnetic resonance imaging evaluation of antiresorptive and antiinflammatory drugs as preventive treatments of osteoarthritis in the rat.

Arthritis and rheumatism 20100901

[Dementia and fracture].

Clinical calcium 20100901

[Jaw osteonecrosis induced by oral biphosphonates: 12 cases].

Revue de stomatologie et de chirurgie maxillo-faciale 20100901

The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100801

Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack.

Acta orthopaedica 20100801

Effect of risedronate on bone resorption during consolidation phase of distraction osteogenesis: a rabbit model.

Journal of orthopaedic surgery (Hong Kong) 20100801

Effects of the bisphosphonate risedronate on osteopenia in OASIS-deficient mice.

Journal of bone and mineral metabolism 20100701

Efficacy, tolerability, and safety of risedronate in Japanese patients with Paget's disease of bone.

Journal of bone and mineral metabolism 20100701

How do bisphosphonates inhibit bone metastasis in vivo?

Neoplasia (New York, N.Y.) 20100701

[Osteoporosis management in general practice. Preventing spontaneous bone fractures].

MMW Fortschritte der Medizin 20100701

Open-label trial: effect of weekly risedronate immediately after transplantation in kidney recipients.

Transplantation 20100627

Longitudinal change in clinical fracture incidence after initiation of bisphosphonates.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100601

Effects of treatment with risedronate and alfacalcidol on progression of atherosclerosis in postmenopausal women with type 2 diabetes mellitus accompanied with osteoporosis.

The American journal of the medical sciences 20100601

Risedronate-induced arthritis.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20100601

Synthesis, chiral high performance liquid chromatographic resolution and enantiospecific activity of a potent new geranylgeranyl transferase inhibitor, 2-hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic acid.

Journal of medicinal chemistry 20100513

Atypical femoral fractures and bisphosphonate use.

The New England journal of medicine 20100513

An in vitro assay to measure targeted drug delivery to bone mineral.

ChemMedChem 20100503

Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100501

How patients' lack of knowledge about oral bisphosphonates can interfere with medical and dental care.

Journal of the American Dental Association (1939) 20100501

Osteonecrosis of the jawbones in 2 osteoporosis patients treated with nitrogen-containing bisphosphonates: osteonecrosis reduction replacing NBP with non-NBP (etidronate) and rationale.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100401

Risedronate versus alendronate in older patients with osteoporosis at high risk of fracture: an Italian cost-effectiveness analysis.

Aging clinical and experimental research 20100401

Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies.

Journal of the American Geriatrics Society 20100401

Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20100301

Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100301

The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100301

The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: a 2-year trial.

Bone 20100301

Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity.

Bone 20100301

Effect of osteoporosis treatment on mortality: a meta-analysis.

The Journal of clinical endocrinology and metabolism 20100301

Response to oral bisphosphonates in subgroups of younger and older postmenopausal women.

Journal of women's health (2002) 20100301

Effects of risedronate on osteoarthritis of the knee.

Yonsei medical journal 20100301

Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100301

Intravenous zoledronic acid: what are the indications for male osteoporosis?

Current osteoporosis reports 20100301

Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100220

Unusual mid-shaft fractures during long-term bisphosphonate therapy.

Clinical endocrinology 20100201

Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years.

Bone 20100201

Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100201

Risedronate decreases bone resorption and improves low back pain in postmenopausal osteoporosis patients without vertebral fractures.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20100201

A randomized, controlled dose-ranging study of risedronate in children with moderate and severe osteogenesis imperfecta.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100101

Risedronate reduces intracortical porosity in women with osteoporosis.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100101

Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice.

Journal of bone and mineral metabolism 20100101

Risedronate prevents early radiation-induced osteoporosis in mice at multiple skeletal locations.

Bone 20100101

Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: results from quantitative computed tomography-based finite element analysis of the vertebral body.

Bone 20100101

Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.

Bone 20100101

Differences between bisphosphonates in binding affinities for hydroxyapatite.

Journal of biomedical materials research. Part B, Applied biomaterials 20100101

Risedronate on 2 consecutive days a month reduced vertebral fracture risk at 1year compared with historical placebo.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20100101

Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone.

Calcified tissue international 20100101

[Diagnosis and treatment of osteoporosis in persons aged more than 75 years].

Revista espanola de geriatria y gerontologia 20100101

Response of serum carboxylated and undercarboxylated osteocalcin to risedronate monotherapy and combined therapy with vitamin K(2) in corticosteroid-treated patients: a pilot study.

Internal medicine (Tokyo, Japan) 20100101

Analysis of risedronate and related substances by ion-pair reversed-phase high-performance liquid chromatography with evaporative light-scattering detection.

Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20100101

Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial.

Breast cancer research : BCR 20100101

Challenges in clinical patient management.

Cancer investigation 20100101

The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation.

Arthritis research & therapy 20100101

Development of an ion-pair reversed-phase HPLC method with indirect UV detection for determination of phosphates and phosphites as impurities in sodium risedronate.

Journal of AOAC International 20100101

Development and validation of a micellar high-performance liquid chromatographic method for determination of risedronate in raw material and in a pharmaceutical formulation: application to stability studies.

Journal of AOAC International 20100101

Risedronate therapy for the prevention of steroid-induced osteoporosis in patients with minimal-change nephrotic syndrome.

Internal medicine (Tokyo, Japan) 20100101

Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis.

Rheumatology international 20091201

Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg.

Current medical research and opinion 20091201

Correlation between serum C-terminal cross-linking telopeptide of type I collagen and staging of oral bisphosphonate-related osteonecrosis of the jaws.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20091201

Review of osteoporosis pharmacotherapy for geriatric patients.

The American journal of geriatric pharmacotherapy 20091201

Prior treatment with vitamin K(2) significantly improves the efficacy of risedronate.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091101

Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091101

Comparison of monthly ibandronate versus weekly risedronate in preference, convenience, and bone turnover markers in Korean postmenopausal osteoporotic women.

Calcified tissue international 20091101

A retrospective clinical and radiographic study on healing of periradicular lesions in patients taking oral bisphosphonates.

Journal of endodontics 20091101

Comparative gastrointestinal safety of weekly oral bisphosphonates.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091001

Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers?

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091001

Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology.

The Journal of clinical endocrinology and metabolism 20091001

Nanostructured polyelectrolyte multilayer drug delivery systems for bone metastasis prevention.

Biomaterials 20091001

Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090901

Cancer-induced bone loss and associated pain-related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE-10790.

International journal of cancer 20090901

Re 'Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors' by A. Luckish et al.

Bone 20090901

Differences in persistence among different weekly oral bisphosphonate medications.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090801

Weekly versus monthly drug regimens: 1-year compliance and persistence with bisphosphonate therapy.

Current medical research and opinion 20090801

[Biochemical markers of bone turnover. New aspect. Biochemical markers of bone turnover in long term treatment with bisphosphonate].

Clinical calcium 20090801

Corticosteroids: no drug prevention of fractures needed.

Prescrire international 20090801

Effects of risedronate on bone turnover markers in osteoporotic postmenopausal women: comparison of two protocols of treatment.

La Tunisie medicale 20090801

Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.

Maturitas 20090720

Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090701

Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss.

Biological & pharmaceutical bulletin 20090701

[Acute exacerbation of a chronic esophagitis].

Deutsche medizinische Wochenschrift (1946) 20090701

DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601

Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601

RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601

Bone microdamage.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090601

Risedronate recovers bone loss in patients with prostate cancer undergoing androgen-deprivation therapy.

Urology 20090601

Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090601

Synergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts.

The Journal of pharmacy and pharmacology 20090601

Effects of risedronate on bone turnover markers in osteoporotic postmenopausal women: comparison of two protocols of treatment.

La Tunisie medicale 20090601

Theoretical analysis of alendronate and risedronate effects on canine vertebral remodeling and microdamage.

Journal of biomechanics 20090511

Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.

Bone 20090501

Improved GI tolerability with monthly ibandronate in women previously using weekly bisphosphonates.

Southern medical journal 20090501

Osteonecrosis associated with short-term oral administration of bisphosphonate.

The Journal of prosthetic dentistry 20090501

[Risedronate for treatment of osteoporosis].

Nihon rinsho. Japanese journal of clinical medicine 20090501

Comparison of the effect of vitamin K(2) and risedronate on trabecular bone in glucocorticoid-treated rats: a bone histomorphometry study.

Yonsei medical journal 20090430

Glucocorticoid-induced osteoporosis: hope on the HORIZON.

Lancet (London, England) 20090411

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.

Lancet (London, England) 20090411

Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090401

Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone.

Bone 20090401

Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate.

The Annals of pharmacotherapy 20090401

Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy.

The Journal of hand surgery 20090401

[Postmenopausal osteoporosis. Bisphosphonates are not all equal].

MMW Fortschritte der Medizin 20090312

[Patient compliance program aids therapy success].

MMW Fortschritte der Medizin 20090312

Effect of risedronate in a minipig cartilage defect model with allograft.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20090301

Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090301

LRP5 Polymorphisms and response to risedronate treatment in osteoporotic men.

Calcified tissue international 20090301

Dental implants in a patient with Paget disease under bisphosphonate treatment: a case report.

Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20090301

Transcriptome and proteome analysis of osteocytes treated with nitrogen-containing bisphosphonates.

Journal of proteome research 20090301

Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment.

Current osteoporosis reports 20090301

Vitamin D status and response to treatment in post-menopausal osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090201

Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis.

The American journal of medicine 20090201

Monaural diplacusis with tinnitus, aural fullness, hyperacusis, and sensorineural hearing loss.

Ear, nose, & throat journal 20090201

Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: a phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study.

Clinical therapeutics 20090201

Paget's disease 2: exploring diagnosis, management and support strategies.

Nursing times 20090201

Bisphosphonate therapy ameliorates hearing loss in mice lacking osteoprotegerin.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090101

Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study.

Rheumatology international 20090101

The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates.

QJM : monthly journal of the Association of Physicians 20090101

Effects of short-term risedronate on bone resorption and patient satisfaction in postmenopausal osteoporosis patients.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20090101

[New development in bisphosphonate treatment. Characteristics and effectiveness of intermittent bisphophonates].

Clinical calcium 20090101

New bisphosphonates and trends in drug therapy for osteoporosis: preface.

Clinical calcium 20090101

[Examination of beneficial effects of risedronate in improving quality of life during long-term treatment of primary osteoporosis].

Nihon rinsho. Japanese journal of clinical medicine 20090101

Effects of risedronate or alfacalcidol on bone mineral density, bone turnover, back pain, and fractures in Japanese men with primary osteoporosis: results of a two-year strict observational study.

Journal of bone and mineral metabolism 20090101

Comparison of the analgesic effects of bisphosphonates: etidronate, alendronate and risedronate by electroalgometry utilizing the fall of skin impedance.

Journal of bone and mineral metabolism 20090101

Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis.

PloS one 20090101

The effect of risedronate treatment on serum cytokines in postmenopausal osteoporosis: a 6-month randomized and controlled study.

Journal of bone and mineral metabolism 20090101

Heterotopic ossification in systemic sclerosis.

Scandinavian journal of rheumatology 20090101

Value of a new fixed-combination pack of bisphosphonate, calcium and vitamin D in the therapy of osteoporosis: results of two quantitative patient research studies.

Drugs & aging 20090101

Anti-fracture efficacy of risedronic acid in men: A meta-analysis of randomized controlled trials.

Clinical drug investigation 20090101

Risedronate on two consecutive days per month.

Drugs & aging 20090101

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis.

Clinical interventions in aging 20090101

The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis.

BMC musculoskeletal disorders 20090101

Risedronate inhibits human osteosarcoma cell invasion.

Journal of experimental & clinical cancer research : CR 20090101

Identification of secondary targets of N-containing bisphosphonates in mammalian cells via parallel competition analysis of the barcoded yeast deletion collection.

Genome biology 20090101

Prevention of hip fractures by exposure to sunlight and pharmacotherapy in patients with Alzheimer's disease.

Aging clinical and experimental research 20090101

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis.

Clinical interventions in aging 20090101

Evaluation of the effect of 4 months of risedronate therapy on femoral strength using femoral strength analysis tools.

The Journal of international medical research 20090101

Geranylgeranyl transferase type II inhibition prevents myeloma bone disease.

Biochemical and biophysical research communications 20081212

Effect of temporal changes in bone turnover on the bone mineralization density distribution: a computer simulation study.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20081201

A new dinuclear platinum complex with a nitrogen-containing geminal bisphosphonate as potential anticancer compound specifically targeted to bone tissues.

Journal of inorganic biochemistry 20081201

[Non traumatic tooth extraction in patients treated by bisphosphonate].

Revue de stomatologie et de chirurgie maxillo-faciale 20081201

Fluorescently labeled risedronate and related analogues: 'magic linker' synthesis.

Bioconjugate chemistry 20081201

Evaluation by digital subtraction radiography of induced changes in the bone density of the female rat mandible.

Dento maxillo facial radiology 20081201

Kinetic study on hemipenta hydrate risedronate monosodium in batch crystallization by cooling mode.

International journal of pharmaceutics 20081119

Compatibility of risedronate sodium tablets with food thickeners.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081115

Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo.

Cancer research 20081101

Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization.

Arthritis and rheumatism 20081101

Effects of risedronate in a rat model of osteopenia due to orchidectomy and disuse: densitometric, histomorphometric and microtomographic studies.

Micron (Oxford, England : 1993) 20081001

Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20081001

Identification of material parameters based on Mohr-Coulomb failure criterion for bisphosphonate treated canine vertebral cancellous bone.

Bone 20081001

Cutaneous vasculitis induced by risedronate.

Allergy 20081001

[Efficacy and tolerability of risedronate for the treatment of osteoporosis].

Clinical calcium 20081001

Effects of risedronate on alveolar bone loss and angiogenesis: a stereologic study in rats.

Journal of periodontology 20081001

Paget disease of bone: therapeutic options.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20081001

[Treatment of osteoporosis in the elderly: what is the evidence?].

Tijdschrift voor gerontologie en geriatrie 20081001

[Severe oesophagus injury as a complication during treatment with risedronic acid].

Nederlands tijdschrift voor geneeskunde 20080927

Monthly risedronate (Actonel) for postmenopausal osteoporosis.

The Medical letter on drugs and therapeutics 20080908

Nonvertebral fracture risk reduction with nitrogen-containing bisphosphonates.

Current osteoporosis reports 20080901

IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole.

Expert review of anticancer therapy 20080901

Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations.

The American journal of managed care 20080901

Changes in urinary NTX levels in patients with primary osteoporosis undergoing long-term bisphosphonate treatment.

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20080901

Osteoporosis in men.

The New England journal of medicine 20080821

Osteoporosis treatment and fracture incidence: the ICARO longitudinal study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080801

Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors.

Bone 20080801

Effect of risedronate on hip structural geometry: a 1-year, double-blind trial in chemotherapy-induced postmenopausal women.

Bone 20080801

Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats.

Calcified tissue international 20080801

Maximizing effectiveness of bisphosphonate therapy for osteoporosis.

Southern medical journal 20080801

Potential excessive suppression of bone turnover with long-term oral bisphosphonate therapy in postmenopausal osteoporotic patients.

Climacteric : the journal of the International Menopause Society 20080801

Determination of the microscopic equilibrium dissociation constants for risedronate and its analogues reveals two distinct roles for the nitrogen atom in nitrogen-containing bisphosphonate drugs.

Journal of medicinal chemistry 20080724

Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080701

Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women.

British journal of clinical pharmacology 20080701

Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats.

The Chinese journal of physiology 20080630

Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial.

Osteoarthritis and cartilage 20080601

Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial.

International journal of clinical practice 20080601

Risedronate prevents bone loss in breast cancer survivors: a 2-year, randomized, double-blind, placebo-controlled clinical trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080601

Secondary osteoporosis in long-term bedridden patients with cerebral palsy.

Pediatrics international : official journal of the Japan Pediatric Society 20080601

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis.

Clinical interventions in aging 20080601

Summaries for patients. Drug therapy for osteoporosis.

Annals of internal medicine 20080506

Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture.

Annals of internal medicine 20080506

Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period.

Annals of the rheumatic diseases 20080501

Effects of risedronate on fracture risk in postmenopausal women with osteopenia.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080501

Greater first year effectiveness drives favorable cost-effectiveness of brand risedronate versus generic or brand alendronate: modeled Canadian analysis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080501

Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.

Bone 20080501

Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis.

Current medical research and opinion 20080501

Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials.

Current medical research and opinion 20080501

Farnesyl pyrophosphate synthase enantiospecificity with a chiral risedronate analog, [6,7-dihydro-5H-cyclopenta[c]pyridin-7-yl(hydroxy)methylene]bis(phosphonic acid) (NE-10501): Synthetic, structural, and modeling studies.

Bioorganic & medicinal chemistry letters 20080501

Esophageal transit and in vivo disintegration of branded risedronate sodium tablets and two generic formulations of alendronic acid tablets: a single-center, single-blind, six-period crossover study in healthy female subjects.

Clinical therapeutics 20080501

Can a disorder of the vestibular system underlie an etiology for migraine?

Ear, nose, & throat journal 20080501

Osteoporotic fracture management in India: a survey of orthopaedic surgeons.

Journal of the Indian Medical Association 20080501

Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: a randomized, controlled trial.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20080401

A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International.

International journal of clinical practice 20080401

In vitro disintegration and dissolution studies of once-weekly copies of alendronate sodium tablets (70 mg) and in vivo implications.

Current medical research and opinion 20080401

Effect of risedronate on biochemical marker of bone resorption in postmenopausal women with osteoporosis or osteopenia.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20080401

Osteonecrosis of the jaw: new developments in an old disease.

The Journal of rheumatology 20080401

Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20080401

Fracture risk remains reduced one year after discontinuation of risedronate.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301

Risedronate reduces osteoclast precursors and cytokine production in postmenopausal osteoporotic women.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20080301

Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301

Preservation of periarticular cancellous morphology and mechanical stiffness in post-traumatic experimental osteoarthritis by antiresorptive therapy.

Clinical biomechanics (Bristol, Avon) 20080301

Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301

A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.

Current medical research and opinion 20080301

Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results.

The Journal of rheumatology 20080301

[Variance of expressions of extracellular matrix components and effects of anti-osteoporotic drugs on Mönckeberg's arteriosclerosis].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20080301

[Radius shaft fracture in a 31-year old man].

Revista clinica espanola 20080201

NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model.

Journal of the American Chemical Society 20080130

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

The Cochrane database of systematic reviews 20080123

Changes in vertebral strength-density and energy absorption-density relationships following bisphosphonate treatment in beagle dogs.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080101

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis.

Bone 20080101

The cost-effectiveness of risedronate treatment in Japanese women with osteoporosis.

Journal of bone and mineral metabolism 20080101

[Patient's preference for the daily and weekly bisphosphonate--evaluation from questionnaire of osteoporosis patients].

Nihon rinsho. Japanese journal of clinical medicine 20080101

Higher efficacy of urinary bone resorption marker measurements in assessing response to treatment for osteoporosis in postmenopausal women.

The Tohoku journal of experimental medicine 20080101

[Guide for the prevention and treatment of glucocorticoid-induced osteoporosis of the Spanish Society of Internal Medicine].

Revista clinica espanola 20080101

[Clinical significance of risedronate for patients with prostate cancer receiving androgen deprivation therapy].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20080101

Effects of bisphosphonates on fracture incidence and bone metabolism in rheumatoid arthritis patients in general practice taking long-term corticosteroid therapy: a retrospective study.

Clinical drug investigation 20080101

Efficacy of risedronate in Japanese male patients with primary osteoporosis.

Internal medicine (Tokyo, Japan) 20080101

Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial.

Journal of bone and mineral metabolism 20080101

Effect of risedronate on bone mass, remodelling and biomechanical strength in orchidectomized rats.

Hormone research 20080101

Urinary osteocalcin and other markers of bone metabolism: the effect of risedronate therapy.

Scandinavian journal of clinical and laboratory investigation 20080101

Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease: a prospective, parallel, open-label, two-year extension study.

Menopause (New York, N.Y.) 20080101

Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.

Anticancer research 20080101

Analgesic and chondroprotective effects of risedronate in osteoarthritis assessed by electroalgometry and measurement of collagen type II fragments in urine.

The Journal of international medical research 20080101

[Differences among bisfosfonates--specificity of risedronate (Actonel)].

Reumatizam 20080101

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system.

BMC musculoskeletal disorders 20080101

Medical treatment of otosclerosis: rationale for use of bisphosphonates.

The international tinnitus journal 20080101

Cost effectiveness and cost utility of risedronate for osteoporosis treatment and fracture prevention in women: a Swiss perspective.

Journal of medical economics 20080101

Hip fractures in users of first- vs. second-generation bisphosphonates.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20071201

Monthly dosing with risedronate 50 mg on three consecutive days a month compared with daily dosing with risedronate 5 mg: a 6-month pilot study.

Current medical research and opinion 20071201

Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20071201

Preventive effect of risedronate on bone loss in men receiving androgen-deprivation therapy for prostate cancer.

International journal of urology : official journal of the Japanese Urological Association 20071201

Evidence based medicine and effective interventions of pharmacological therapy for the prevention of osteoporotic fractures.

Minerva endocrinologica 20071201

Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate.

Journal of medicinal chemistry 20071129

[HIP study--how to prevent hip fractures?].